Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cirrhotic ascites: pathogenesis and management

G Garcia-Tsao1

  • 1Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT 06520, USA.

The Gastroenterologist
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invasive Fungal Infections Are Underdiagnosed in Hospitalized Patients With Decompensated Cirrhosis: An Autopsy Study.

Gastro hep advances·2022
Same author

Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

The American journal of gastroenterology·2022
Same author

The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

The American journal of gastroenterology·2021
Same author

Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation.

Alimentary pharmacology & therapeutics·2017
Same author

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.

The American journal of gastroenterology·2017
Same author

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Journal of medical genetics·2009

Ascites pathogenesis involves fluid shifts and retention, often linked to cirrhosis. Current treatments focus on sodium balance and fluid removal, with liver transplantation considered for refractory cases.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Ascites, a common cirrhosis complication, arises from sinusoidal hypertension, hypoalbuminemia, thoracic duct issues, and sodium/water retention.
  • Current therapeutic strategies primarily aim to achieve negative sodium balance and manage fluid accumulation.
  • Despite available treatments, a subset of patients develop diuretic-refractory ascites, indicating a poor prognosis.

Purpose of the Study:

  • To outline the multifaceted pathogenesis of ascites.
  • To review current therapeutic approaches for managing ascites.
  • To identify future research directions and treatment considerations for refractory ascites.

Main Methods:

  • Review of established etiological factors contributing to ascites formation.

Related Experiment Videos

  • Analysis of current clinical practices for ascites management, including sodium restriction, diuretics, and fluid removal techniques.
  • Discussion of emerging therapeutic concepts and prognostic indicators.

    • Main Results:

    • Ascites pathogenesis is multifactorial, involving vascular-to-peritoneal fluid efflux, peritoneal fluid accumulation, and intravascular volume repletion.
    • Over 90% of patients with ascites respond to standard treatments like diuretics and salt restriction.
    • Diuretic-refractory ascites represents a significant challenge with a poor prognosis, often necessitating consideration of liver transplantation.

    Conclusions:

    • Understanding the complex pathogenesis of ascites is crucial for effective management.
    • Standard therapies are effective for most patients, but refractory cases require advanced interventions.
    • Future research should explore novel treatments like portosystemic shunting and vasoconstrictors for sinusoidal hypertension.